Supplementary Table S1 from Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1CMark H. O’Hara,Opeyemi Jegede,Mark A. Dickson,Angela M. DeMichele,Richard Piekarz,Robert J. Gray,Victoria Wang,Lisa M. McShane,Lawrence V. Rubinstein,David R. Patton,P. Mickey Williams,Stanley R. Hamilton,Adedayo Onitilo,James V. Tricoli,Barbara A. Conley,Carlos L. Arteaga,Lyndsay N. Harris,Peter J. O’Dwyer,Alice P. Chen,Keith T. Flahertycrossref(2025)引用 0|浏览2AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要